Corteva (CTVA) Financials

$69.13 +0.32 (+0.47%)

As of 05/20/2025 03:58 PM Eastern

Annual Income Statements for Corteva

This table shows Corteva's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Net Income / (Loss) Attributable to Common Shareholders	907	735	1,147	1,759	681	-959	-5,065
Consolidated Net Income / (Loss)	919	747	1,158	1,769	701	-941	-5,027
Net Income / (Loss) Continuing Operations	863	941	1,216	1,822	756	-270	-6,775
Total Pre-Tax Income	1,275	1,093	1,426	2,346	675	-316	-6,806
Total Operating Income	1,808	1,774	1,565	1,028	508	-382	-6,637
Total Gross Profit	7,379	7,306	7,019	6,435	5,710	5,271	4,339
Total Revenue	16,908	17,226	17,455	15,655	14,217	13,846	14,287
Operating Revenue	16,908	17,226	17,455	15,655	14,217	13,846	14,287
Total Cost of Revenue	9,529	9,920	10,436	9,220	8,507	8,575	9,948
Operating Cost of Revenue	9,529	9,920	10,436	9,220	8,507	8,575	9,948
Total Operating Expenses	5,571	5,532	5,454	5,407	5,202	5,653	10,976
Selling, General & Admin Expense	3,196	3,176	3,173	3,209	3,043	3,065	3,041
Research & Development Expense	1,402	1,337	1,216	1,187	1,142	1,147	1,355
Amortization Expense	685	683	702	722	682	475	391
Restructuring Charge	288	336	363	289	335	222	694
Total Other Income / (Expense), net	-533	-681	-139	1,318	167	66	-169
Interest Expense	233	233	79	30	45	149	418
Other Income / (Expense), net	-300	-448	-60	1,348	212	215	249
Income Tax Expense	412	152	210	524	-81	-46	-31
Net Income / (Loss) Discontinued Operations	56	-194	-58	-53	-55	-671	1,748
Net Income / (Loss) Attributable to Noncontrolling Interest	12	12	11	10	20	18	38
Basic Earnings per Share	$1.31	$1.04	$1.59	$2.39	$0.91	($1.28)	($6.76)
Weighted Average Basic Shares Outstanding	685.56M	701.78M	712.82M	727.02M	744.06M	749.40M	-
Diluted Earnings per Share	$1.30	$1.03	$1.58	$2.37	$0.91	($1.28)	($6.76)
Weighted Average Diluted Shares Outstanding	685.56M	701.78M	712.82M	727.02M	744.06M	749.40M	-
Weighted Average Basic & Diluted Shares Outstanding	685.56M	701.78M	712.82M	727.02M	744.06M	749.40M	-
Cash Dividends to Common per Share	$0.66	-	-	$0.54	$0.52	$0.26	-

This table shows Corteva's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-41	-524	1,053	419	-253	-321	714	595	-55	-331
Consolidated Net Income / (Loss)	-39	-521	1,056	423	-251	-318	717	599	-53	-328
Net Income / (Loss) Continuing Operations	-50	-519	1,056	376	-231	-315	880	607	-41	-322
Total Pre-Tax Income	88	-633	1,338	482	-323	-444	1,084	776	2,451	-396
Total Operating Income	129	-460	1,517	622	-167	-237	1,300	878	-18	-401
Total Gross Profit	1,482	761	3,194	1,942	1,341	944	2,908	2,113	1,315	898
Total Revenue	3,978	2,326	6,112	4,492	3,707	2,590	6,045	4,884	3,825	2,777
Operating Revenue	3,978	2,326	6,112	4,492	3,707	2,590	6,045	4,884	3,825	2,777
Total Cost of Revenue	2,496	1,565	2,918	2,550	2,366	1,646	3,137	2,771	2,510	1,879
Operating Cost of Revenue	2,496	1,565	2,918	2,550	2,366	1,646	3,137	2,771	2,510	1,879
Total Operating Expenses	1,353	1,221	1,677	1,320	1,508	1,181	1,608	1,235	1,333	1,299
Selling, General & Admin Expense	735	671	1,054	736	735	670	1,045	726	764	657
Research & Development Expense	365	348	357	332	357	335	329	316	340	312
Amortization Expense	164	170	174	177	175	174	174	160	166	178
Restructuring Charge	89	32	92	75	241	2.00	60	33	63	152
Total Other Income / (Expense), net	-41	-173	-179	-140	-156	-207	-216	-102	-185	5.00
Interest Expense	60	66	66	41	62	58	82	31	36	18
Other Income / (Expense), net	19	-107	-113	-99	-94	-149	-134	-71	-149	23
Income Tax Expense	138	-114	282	106	-92	-129	204	169	-162	-74
Net Income / (Loss) Discontinued Operations	11	-2.00	0.00	47	-20	-3.00	-163	-8.00	-12	-6.00
Net Income / (Loss) Attributable to Noncontrolling Interest	2.00	3.00	3.00	4.00	2.00	3.00	3.00	4.00	2.00	3.00
Basic Earnings per Share	($0.04)	($0.76)	$1.51	$0.60	($0.35)	($0.45)	$1.00	$0.84	($0.07)	($0.46)
Weighted Average Basic Shares Outstanding	685.56M	687.29M	692.25M	696.98M	701.78M	704.73M	709.76M	710.87M	712.82M	714.49M
Diluted Earnings per Share	($0.05)	($0.76)	$1.51	$0.60	($0.35)	($0.45)	$1.00	$0.83	($0.07)	($0.46)
Weighted Average Diluted Shares Outstanding	685.56M	687.29M	692.25M	696.98M	701.78M	704.73M	709.76M	710.87M	712.82M	714.49M
Weighted Average Basic & Diluted Shares Outstanding	685.56M	687.29M	692.25M	696.98M	701.78M	704.73M	709.76M	710.87M	712.82M	714.49M

This table details how cash moves in and out of Corteva's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Net Change in Cash & Equivalents	528	-920	-2,436	-198	1,700	-2,851	3,613
Net Cash From Operating Activities	4,332	5,225	1,711	2,727	2,064	1,070	483
Net Cash From Continuing Operating Activities	4,634	5,345	1,791	2,769	2,064	-149	374
Net Income / (Loss) Continuing Operations	1,756	1,867	2,398	1,822	701	-941	-5,027
Consolidated Net Income / (Loss)	1,868	1,479	2,282	1,769	701	-941	5,027
Net Income / (Loss) Discontinued Operations	112	-388	-116	-53	-	-	-
Depreciation Expense	2,454	2,422	2,446	1,243	1,177	1,599	2,790
Non-Cash Adjustments To Reconcile Net Income	1,326	1,762	652	-1,117	19	-161	5,208
Changes in Operating Assets and Liabilities, net	-902	-2,474	-3,705	821	167	-918	-4,225
Net Cash From Discontinued Operating Activities	-302	-80	-80	-42	-	-	-
Net Cash From Investing Activities	-817	-6,001	-1,264	-362	-674	-904	-505
Net Cash From Continuing Investing Activities	-817	-3,994	-1,264	-362	-674	-904	-505
Purchase of Property, Plant & Equipment	-1,194	-1,190	-1,210	-573	-475	-1,163	-1,501
Acquisitions	-14	-2,976	-96	-4.00	-1.00	-20	-8.00
Purchase of Investments	-288	-296	-688	-204	-995	-138	-1,257
Divestitures	10	114	146	75	83	270	78
Sale and/or Maturity of Investments	386	378	590	345	721	160	2,186
Other Investing Activities, net	283	-24	-6.00	-1.00	-7.00	-13	-3.00
Net Cash From Financing Activities	-2,801	-175	-2,327	-1,266	303	-2,929	-2,624
Net Cash From Continuing Financing Activities	-2,801	-137	-2,327	-2,563	1,199	2,357	3,744
Repayment of Debt	-5,825	-5,850	-3,823	-1,800	-1,469	-6,758	-6,422
Repurchase of Common Equity	-1,009	-756	-1,000	-950	-275	-25	0.00
Payment of Dividends	-2,337	-439	-418	-397	-448	511	-2,806
Issuance of Debt	6,250	6,846	2,738	484	2,439	-867	1,156
Other Financing Activities, net	120	62	176	100	56	9,496	5,448
Other Net Changes in Cash	-186	-286	-556	-	7.00	-88	-
Cash Interest Paid	488	468	150	30	36	263	923
Cash Income Taxes Paid	1,414	1,070	934	341	229	234	961

This table details how cash moves in and out of Corteva's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	1,332	1,230	254	-2,288	749	-1,014	-783	128	1,998	-4,019
Net Cash From Operating Activities	9,494	-114	536	-5,584	7,829	-105	812	-3,311	6,009	-2,677
Net Cash From Continuing Operating Activities	9,482	-118	848	-5,578	7,919	-94	822	-3,302	6,203	-4,326
Net Income / (Loss) Continuing Operations	-99	-1,024	2,122	757	695	-315	880	607	1.00	858
Consolidated Net Income / (Loss)	-77	-1,028	2,122	851	481	-318	717	599	-115	858
Net Income / (Loss) Discontinued Operations	22	-4.00	-	94	-214	-3.00	-163	-8.00	-	-
Depreciation Expense	604	612	624	614	1,523	306	-	-	608	-
Non-Cash Adjustments To Reconcile Net Income	-34	406	450	504	1,232	174	288	68	34	-
Changes in Operating Assets and Liabilities, net	9,011	-112	-2,348	-7,453	2,701	-222	337	-5,290	5,560	-7,640
Net Cash From Discontinued Operating Activities	12	4.00	-312	-6.00	-50	-11	-10	-9.00	-	-
Net Cash From Investing Activities	115	-322	-70	-540	-4,228	-229	-33	-1,511	-386	-443
Net Cash From Continuing Investing Activities	115	-322	-70	-540	-2,221	-263	-2,988	1,478	-386	-443
Purchase of Property, Plant & Equipment	-362	-308	-228	-296	-778	-162	-99	-151	-290	-602
Purchase of Investments	-14	-2.00	-8.00	-264	-213	-76	-7.00	0.00	-60	-392
Divestitures	6.00	-36	30	10	72	-26	26	42	54	80
Sale and/or Maturity of Investments	126	100	146	14	209	21	24	124	42	455
Other Investing Activities, net	359	-62	-10	-4.00	-22	-	-2.00	0.00	-54	28
Net Cash From Financing Activities	-8,181	1,612	-130	3,898	-3,778	224	105	3,274	-3,659	1,226
Net Cash From Continuing Financing Activities	-8,181	1,612	-130	3,898	-2,845	-671	105	3,274	-3,659	1,226
Repayment of Debt	-2,718	-1,172	-1,519	-416	-3,567	-1,869	-330	-84	-1,891	-1,682
Repurchase of Common Equity	-252	-253	-252	-252	-171	-253	-80	-252	-200	-200
Payment of Dividends	-1,997	-117	-111	-112	-112	-114	-106	-107	-107	-108
Issuance of Debt	-3,274	3,150	1,712	4,662	971	1,563	602	3,710	-1,505	3,146
Other Financing Activities, net	60	4.00	40	16	34	2.00	19	7.00	44	70
Other Net Changes in Cash	-96	54	-82	-62	-	-	-	-	34	-

This table presents Corteva's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Assets	40,825	42,996	42,618	42,344	42,649	42,397	217,366
Total Current Assets	15,097	16,260	16,795	15,546	14,768	13,519	45,944
Cash & Equivalents	3,106	2,644	3,191	4,459	3,526	1,764	4,540
Short-Term Investments	63	98	124	86	269	5.00	10
Accounts Receivable	5,676	5,488	5,701	4,811	4,926	5,528	10,520
Inventories, net	5,432	6,899	6,811	5,180	4,882	5,032	10,620
Other Current Assets	820	1,131	968	1,010	1,165	1,190	2,076
Plant, Property, & Equipment, net	4,099	4,287	4,254	4,329	4,396	4,546	9,088
Plant, Property & Equipment, gross	9,074	8,956	8,551	8,364	8,253	7,872	14,680
Accumulated Depreciation	4,975	4,669	4,297	4,035	3,857	3,326	5,592
Total Noncurrent Assets	21,629	22,449	21,569	22,469	23,485	24,332	162,334
Long-Term Investments	134	115	102	76	66	66	276
Goodwill	10,408	10,605	9,962	10,107	10,269	10,229	20,386
Intangible Assets	8,876	9,626	9,339	10,044	10,747	11,424	24,110
Noncurrent Deferred & Refundable Income Taxes	401	584	479	438	464	287	608
Other Noncurrent Operating Assets	1,810	1,519	1,687	1,804	1,939	2,326	3,864
Total Liabilities & Shareholders' Equity	40,825	42,996	42,618	42,344	42,649	42,397	217,366
Total Liabilities	16,795	17,717	17,077	16,721	17,586	17,842	67,060
Total Current Liabilities	10,386	10,409	10,744	9,558	8,548	8,238	26,620
Short-Term Debt	750	198	24	17	3.00	7.00	4,308
Accounts Payable	4,039	4,280	4,895	4,126	3,615	3,702	7,596
Accrued Expenses	2,103	2,351	2,254	2,068	2,145	4,434	8,010
Current Deferred Revenue	3,287	3,406	3,388	3,201	2,662	-	-
Current Deferred & Payable Income Tax Liabilities	207	174	183	146	123	95	372
Total Noncurrent Liabilities	6,409	7,308	6,333	7,163	9,038	9,604	40,440
Long-Term Debt	1,953	2,291	1,283	1,100	1,102	115	11,568
Noncurrent Deferred & Payable Income Tax Liabilities	478	899	1,119	1,220	893	920	2,960
Noncurrent Employee Benefit Liabilities	2,271	2,467	2,255	3,124	5,176	6,377	11,354
Other Noncurrent Operating Liabilities	1,707	1,651	1,676	1,719	1,867	2,192	3,590
Total Equity & Noncontrolling Interests	24,030	25,279	25,541	25,623	25,063	24,555	150,306
Total Preferred & Common Equity	23,789	25,037	25,302	25,384	24,824	24,309	149,559
Preferred Stock	0.00	0.00	0.00	0.00	-	-	0.00
Total Common Equity	23,789	25,037	25,302	25,384	24,824	24,309	149,559
Common Stock	27,203	27,755	27,858	27,758	27,714	28,004	0.00
Retained Earnings	55	-41	250	524	-	-425	0.00
Accumulated Other Comprehensive Income / (Loss)	-3,469	-2,677	-2,806	-2,898	-2,890	-3,270	-6,720
Noncontrolling Interest	241	242	239	239	239	246	747

This table presents Corteva's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	40,825	41,908	41,464	43,625	42,996	43,110	44,189	45,500	42,618	40,651
Total Current Assets	15,097	15,649	15,359	17,163	16,260	16,333	17,207	18,329	16,795	15,045
Cash & Equivalents	3,106	2,421	1,839	1,505	2,644	2,254	2,563	1,646	3,191	2,199
Short-Term Investments	63	72	120	153	98	108	53	85	124	119
Accounts Receivable	5,676	6,651	7,615	7,906	5,488	6,581	7,955	8,678	5,701	6,273
Inventories, net	5,432	5,674	4,893	6,183	6,899	6,320	5,628	6,585	6,811	5,415
Other Current Assets	820	831	892	1,416	1,131	1,070	1,008	1,335	968	1,039
Plant, Property, & Equipment, net	4,099	4,210	4,155	4,206	4,287	4,320	4,306	4,271	4,254	4,185
Plant, Property & Equipment, gross	9,074	9,235	9,088	9,013	8,956	8,892	8,797	8,633	8,551	8,444
Accumulated Depreciation	4,975	5,025	4,933	4,807	4,669	4,572	4,491	4,362	4,297	4,259
Total Noncurrent Assets	21,629	22,049	21,950	22,256	22,449	22,457	22,676	22,900	21,569	21,421
Long-Term Investments	134	128	113	123	115	106	83	87	102	91
Goodwill	10,408	10,629	10,490	10,553	10,605	10,441	10,539	10,508	9,962	9,791
Intangible Assets	8,876	9,084	9,238	9,446	9,626	9,795	9,985	10,137	9,339	9,461
Noncurrent Deferred & Refundable Income Taxes	401	564	538	551	584	554	524	508	479	407
Other Noncurrent Operating Assets	1,810	1,644	1,571	1,583	1,519	1,561	1,545	1,660	1,687	1,671
Total Liabilities & Shareholders' Equity	40,825	41,908	41,464	43,625	42,996	43,110	44,189	45,500	42,618	40,651
Total Liabilities	16,795	16,929	16,043	18,617	17,717	17,758	17,728	19,661	17,077	15,567
Total Current Liabilities	10,386	10,424	8,953	11,332	10,409	10,348	10,346	13,231	10,744	8,918
Short-Term Debt	750	3,741	2,253	2,148	198	3,724	3,023	3,787	24	1,576
Accounts Payable	4,039	3,753	3,300	3,606	4,280	3,678	3,379	3,957	4,895	4,140
Accrued Expenses	2,103	2,188	2,499	2,573	2,351	2,273	2,892	2,477	2,254	2,115
Current Deferred Revenue	3,287	429	413	2,694	3,406	552	656	2,712	3,388	860
Current Deferred & Payable Income Tax Liabilities	207	313	488	311	174	236	396	298	183	227
Total Noncurrent Liabilities	6,409	6,505	7,090	7,285	7,308	7,295	7,382	6,430	6,333	6,649
Long-Term Debt	1,953	1,975	2,471	2,492	2,291	2,290	2,290	1,241	1,283	1,277
Noncurrent Deferred & Payable Income Tax Liabilities	478	496	607	753	899	1,070	1,134	1,255	1,119	1,123
Noncurrent Employee Benefit Liabilities	2,271	2,473	2,452	2,453	2,467	2,228	2,236	2,242	2,255	2,628
Other Noncurrent Operating Liabilities	1,707	1,561	1,560	1,587	1,651	1,707	1,722	1,692	1,676	1,621
Total Equity & Noncontrolling Interests	24,030	24,979	25,421	25,008	25,279	25,467	26,461	25,839	25,541	25,084
Total Preferred & Common Equity	23,789	24,737	25,179	24,767	25,037	25,226	26,220	25,599	25,302	24,844
Preferred Stock	0.00	239	0.00	0.00	0.00	239	0.00	0.00	0.00	0.00
Total Common Equity	23,789	24,737	25,179	24,767	25,037	25,226	26,220	25,599	25,302	24,844
Common Stock	27,203	27,525	27,511	27,475	27,755	27,902	27,884	27,851	27,858	27,822
Retained Earnings	55	98	992	302	-41	325	1,013	487	250	614
Accumulated Other Comprehensive Income / (Loss)	-3,469	-2,886	-3,324	-3,010	-2,677	-3,001	-2,677	-2,739	-2,806	-3,592
Noncontrolling Interest	241	242	242	241	242	241	241	240	239	240

This table displays calculated financial ratios and metrics derived from Corteva's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Growth Metrics	-	-	-	-	-	-	-
Revenue Growth	-1.85%	-1.31%	11.50%	10.11%	2.68%	-3.09%	0.00%
EBITDA Growth	5.71%	-5.14%	9.17%	90.77%	11.33%	186.50%	0.00%
EBIT Growth	13.73%	-11.89%	-36.66%	230.00%	531.14%	97.39%	0.00%
NOPAT Growth	-19.87%	14.44%	67.15%	40.32%	312.77%	94.24%	0.00%
Net Income Growth	23.03%	-35.49%	-34.54%	152.35%	174.50%	81.28%	0.00%
EPS Growth	26.21%	-34.81%	-33.33%	160.44%	171.09%	81.07%	0.00%
Operating Cash Flow Growth	-17.09%	205.38%	-37.26%	32.12%	92.90%	121.53%	0.00%
Free Cash Flow Firm Growth	5,618.87%	109.92%	-97.72%	-10.65%	-95.45%	0.00%	0.00%
Invested Capital Growth	-5.95%	6.32%	5.93%	-0.84%	-2.34%	-51.80%	0.00%
Revenue Q/Q Growth	1.63%	-0.68%	2.02%	1.77%	34.16%	113.31%	0.00%
EBITDA Q/Q Growth	21.50%	119.95%	-3.16%	9.73%	-42.09%	-57.15%	0.00%
EBIT Q/Q Growth	37.22%	-6.62%	-21.82%	15.17%	-11.00%	-104.31%	0.00%
NOPAT Q/Q Growth	2.54%	-18.86%	27.01%	-4.16%	-3.18%	-107.25%	0.00%
Net Income Q/Q Growth	29.99%	-20.95%	-15.60%	7.15%	51.08%	-128.66%	0.00%
EPS Q/Q Growth	30.00%	-21.37%	-15.51%	7.24%	10.98%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	649.05%	103.62%	327.53%	9.87%	-3.37%	11.46%	0.00%
Free Cash Flow Firm Q/Q Growth	34.07%	103.18%	-12.33%	5.16%	-60.48%	0.00%	0.00%
Invested Capital Q/Q Growth	-16.54%	-13.80%	-8.21%	-9.73%	-9.35%	-14.81%	0.00%
Profitability Metrics	-	-	-	-	-	-	-
Gross Margin	43.64%	42.41%	40.21%	41.11%	40.16%	38.07%	30.37%
EBITDA Margin	23.43%	21.76%	22.64%	23.12%	13.34%	12.31%	-13.79%
Operating Margin	10.69%	10.30%	8.97%	6.57%	3.57%	-2.76%	-46.45%
EBIT Margin	8.92%	7.70%	8.62%	15.18%	5.06%	-1.21%	-44.71%
Profit (Net Income) Margin	5.44%	4.34%	6.63%	11.30%	4.93%	-6.80%	-35.19%
Tax Burden Percent	72.08%	68.34%	81.21%	75.40%	103.85%	297.78%	73.86%
Interest Burden Percent	84.55%	82.43%	94.75%	98.74%	93.75%	189.22%	106.54%
Effective Tax Rate	32.31%	13.91%	14.73%	22.34%	-12.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	5.06%	6.32%	5.86%	3.59%	2.52%	-0.76%	-9.80%
ROIC Less NNEP Spread (ROIC-NNEP)	68.03%	69.30%	12.15%	-27.42%	-3.39%	0.53%	-9.43%
Return on Net Nonoperating Assets (RNNOA)	-1.34%	-3.38%	-1.33%	3.39%	0.31%	-0.31%	6.46%
Return on Equity (ROE)	3.73%	2.94%	4.53%	6.98%	2.83%	-1.08%	-3.34%
Cash Return on Invested Capital (CROIC)	11.19%	0.20%	0.10%	4.44%	4.89%	69.14%	0.00%
Operating Return on Assets (OROA)	3.60%	3.10%	3.54%	5.59%	1.69%	-0.13%	-2.94%
Return on Assets (ROA)	2.19%	1.75%	2.73%	4.16%	1.65%	-0.72%	-2.31%
Return on Common Equity (ROCE)	3.69%	2.91%	4.48%	6.91%	2.80%	-1.07%	-3.33%
Return on Equity Simple (ROE_SIMPLE)	3.86%	2.98%	4.58%	6.97%	2.82%	-3.87%	-3.36%
Net Operating Profit after Tax (NOPAT)	1,224	1,527	1,335	798	569	-267	-4,646
NOPAT Margin	7.24%	8.87%	7.65%	5.10%	4.00%	-1.93%	-32.52%
Net Nonoperating Expense Percent (NNEP)	-62.97%	-62.98%	-6.29%	31.01%	5.91%	-1.29%	-0.37%
Return On Investment Capital (ROIC_SIMPLE)	4.58%	5.50%	4.97%	-	-	-	-
Cost of Revenue to Revenue	56.36%	57.59%	59.79%	58.89%	59.84%	61.93%	69.63%
SG&A Expenses to Revenue	18.90%	18.44%	18.18%	20.50%	21.40%	22.14%	21.29%
R&D to Revenue	8.29%	7.76%	6.97%	7.58%	8.03%	8.28%	9.48%
Operating Expenses to Revenue	32.95%	32.11%	31.25%	34.54%	36.59%	40.83%	76.83%
Earnings before Interest and Taxes (EBIT)	1,508	1,326	1,505	2,376	720	-167	-6,388
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,962	3,748	3,951	3,619	1,897	1,704	-1,970
Valuation Ratios	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.65	1.33	1.62	1.33	1.12	0.86	0.00
Price to Tangible Book Value (P/TBV)	8.69	6.95	6.84	6.43	7.31	7.89	0.00
Price to Revenue (P/Rev)	2.32	1.94	2.35	2.15	1.96	1.51	0.00
Price to Earnings (P/E)	43.16	45.42	35.77	19.13	40.87	0.00	0.00
Dividend Yield	1.16%	1.31%	1.27%	1.17%	1.74%	0.93%	0.00%
Earnings Yield	2.32%	2.20%	2.80%	5.23%	2.45%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.66	1.34	1.67	1.37	1.13	0.85	0.00
Enterprise Value to Revenue (EV/Rev)	2.29	1.93	2.24	1.94	1.78	1.41	0.00
Enterprise Value to EBITDA (EV/EBITDA)	9.79	8.87	9.91	8.39	13.34	11.43	0.00
Enterprise Value to EBIT (EV/EBIT)	25.72	25.08	26.02	12.79	35.16	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	31.70	21.78	29.34	38.05	44.49	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	8.95	6.37	22.89	11.14	12.26	18.20	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	14.34	703.19	1,738.05	30.80	22.93	0.80	0.00
Leverage & Solvency	-	-	-	-	-	-	-
Debt to Equity	0.11	0.10	0.05	0.04	0.04	0.01	0.11
Long-Term Debt to Equity	0.08	0.09	0.05	0.04	0.04	0.00	0.08
Financial Leverage	-0.02	-0.05	-0.11	-0.12	-0.09	-0.60	-0.68
Leverage Ratio	1.70	1.68	1.66	1.68	1.71	1.49	1.45
Compound Leverage Factor	1.44	1.39	1.57	1.66	1.61	2.81	1.54
Debt to Total Capital	10.11%	8.96%	4.87%	4.18%	4.22%	0.49%	9.55%
Short-Term Debt to Total Capital	2.81%	0.71%	0.09%	0.06%	0.01%	0.03%	2.59%
Long-Term Debt to Total Capital	7.31%	8.25%	4.78%	4.11%	4.21%	0.47%	6.96%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.90%	0.87%	0.89%	0.89%	0.91%	1.00%	0.45%
Common Equity to Total Capital	88.99%	90.16%	94.24%	94.93%	94.86%	98.51%	90.00%
Debt to EBITDA	0.68	0.66	0.33	0.31	0.58	0.07	-8.06
Net Debt to EBITDA	-0.15	-0.10	-0.53	-0.97	-1.45	-1.01	-5.61
Long-Term Debt to EBITDA	0.49	0.61	0.32	0.30	0.58	0.07	-5.87
Debt to NOPAT	2.21	1.63	0.98	1.40	1.94	-0.46	-3.42
Net Debt to NOPAT	-0.49	-0.24	-1.58	-4.39	-4.84	6.41	-2.38
Long-Term Debt to NOPAT	1.60	1.50	0.96	1.38	1.94	-0.43	-2.49
Altman Z-Score	2.08	1.79	2.15	1.95	1.51	1.15	0.00
Noncontrolling Interest Sharing Ratio	0.98%	0.95%	0.93%	0.94%	0.98%	0.57%	0.50%
Liquidity Ratios	-	-	-	-	-	-	-
Current Ratio	1.45	1.56	1.56	1.63	1.73	1.64	1.73
Quick Ratio	0.85	0.79	0.84	0.98	1.02	0.89	0.57
Cash Flow Metrics	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2,705	47	23	986	1,104	24,281	0.00
Operating Cash Flow to CapEx	362.81%	439.08%	141.41%	475.92%	434.53%	92.00%	32.18%
Free Cash Flow to Firm to Interest Expense	11.61	0.20	0.29	32.88	24.53	162.96	0.00
Operating Cash Flow to Interest Expense	18.59	22.42	21.66	90.90	45.87	7.18	1.16
Operating Cash Flow Less CapEx to Interest Expense	13.47	17.32	6.34	71.80	35.31	-0.62	-2.44
Efficiency Ratios	-	-	-	-	-	-	-
Asset Turnover	0.40	0.40	0.41	0.37	0.33	0.11	0.07
Accounts Receivable Turnover	3.03	3.08	3.32	3.22	2.72	1.73	1.36
Inventory Turnover	1.55	1.45	1.74	1.83	1.72	1.10	0.94
Fixed Asset Turnover	4.03	4.03	4.07	3.59	3.18	2.03	1.57
Accounts Payable Turnover	2.29	2.16	2.31	2.38	2.33	1.52	1.31
Days Sales Outstanding (DSO)	120.50	118.54	109.91	113.51	134.20	211.52	268.76
Days Inventory Outstanding (DIO)	236.16	252.23	209.69	199.17	212.68	333.12	389.66
Days Payable Outstanding (DPO)	159.33	168.79	157.76	153.22	156.97	240.45	278.70
Cash Conversion Cycle (CCC)	197.34	201.97	161.85	159.45	189.91	304.19	379.71
Capital & Investment Metrics	-	-	-	-	-	-	-
Invested Capital	23,430	24,911	23,431	22,119	22,307	22,842	47,390
Invested Capital Turnover	0.70	0.71	0.77	0.70	0.63	0.39	0.30
Increase / (Decrease) in Invested Capital	-1,481	1,480	1,312	-188	-535	-24,548	0.00
Enterprise Value (EV)	38,789	33,258	39,159	30,377	25,314	19,477	0.00
Market Capitalization	39,148	33,384	41,030	33,642	27,831	20,944	0.00
Book Value per Share	$34.61	$35.53	$35.41	$34.82	$33.32	$32.48	$0.00
Tangible Book Value per Share	$6.55	$6.82	$8.40	$7.18	$5.11	$3.55	$0.00
Total Capital	26,733	27,768	26,848	26,740	26,168	24,677	166,182
Total Debt	2,703	2,489	1,307	1,117	1,105	122	15,876
Total Long-Term Debt	1,953	2,291	1,283	1,100	1,102	115	11,568
Net Debt	-600	-368	-2,110	-3,504	-2,756	-1,713	11,050
Capital Expenditures (CapEx)	1,194	1,190	1,210	573	475	1,163	1,501
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,292	3,307	2,760	1,460	2,428	3,519	19,082
Debt-free Net Working Capital (DFNWC)	5,461	6,049	6,075	6,005	6,223	5,288	23,632
Net Working Capital (NWC)	4,711	5,851	6,051	5,988	6,220	5,281	19,324
Net Nonoperating Expense (NNE)	305	780	177	-971	-132	674	381
Net Nonoperating Obligations (NNO)	-600	-368	-2,110	-3,504	-2,756	-1,713	-102,916
Total Depreciation and Amortization (D&A)	2,454	2,422	2,446	1,243	1,177	1,871	4,418
Debt-free, Cash-free Net Working Capital to Revenue	13.56%	19.20%	15.81%	9.33%	17.08%	25.42%	133.56%
Debt-free Net Working Capital to Revenue	32.30%	35.12%	34.80%	38.36%	43.77%	38.19%	165.41%
Net Working Capital to Revenue	27.86%	33.97%	34.67%	38.25%	43.75%	38.14%	135.26%
Earnings Adjustments	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.31	$1.04	$1.59	$2.39	$0.91	($1.28)	($6.76)
Adjusted Weighted Average Basic Shares Outstanding	685.56M	701.78M	712.82M	727.02M	744.06M	749.40M	0.00
Adjusted Diluted Earnings per Share	$1.30	$1.03	$1.58	$2.37	$0.91	($1.28)	($6.76)
Adjusted Weighted Average Diluted Shares Outstanding	685.56M	701.78M	712.82M	727.02M	744.06M	749.40M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	($1.28)	($6.76)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	685.56M	701.78M	712.82M	727.02M	744.06M	749.40M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	1,419	1,817	1,644	1,023	590	-112	-1,008
Normalized NOPAT Margin	8.39%	10.55%	9.42%	6.53%	4.15%	-0.81%	-7.06%
Pre Tax Income Margin	7.54%	6.35%	8.17%	14.99%	4.75%	-2.28%	-47.64%
Debt Service Ratios	-	-	-	-	-	-	-
EBIT to Interest Expense	6.47	5.69	19.05	79.20	16.00	-1.12	-15.28
NOPAT to Interest Expense	5.25	6.55	16.89	26.61	12.64	-1.79	-11.11
EBIT Less CapEx to Interest Expense	1.35	0.58	3.73	60.10	5.44	-8.93	-18.87
NOPAT Less CapEx to Interest Expense	0.13	1.45	1.58	7.51	2.09	-9.60	-14.71
Payout Ratios	-	-	-	-	-	-	-
Dividend Payout Ratio	254.30%	58.77%	36.10%	22.44%	63.91%	54.30%	-55.82%
Augmented Payout Ratio	364.09%	159.97%	122.45%	76.14%	103.14%	51.65%	-55.82%

This table displays calculated financial ratios and metrics derived from Corteva's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.31%	-10.19%	1.11%	-8.03%	-3.09%	-6.73%	-3.31%	6.15%	9.95%	17.12%
EBITDA Growth	-40.41%	156.25%	51.34%	17.58%	186.17%	60.00%	-11.96%	-4.64%	-22.63%	-161.54%
EBIT Growth	156.71%	-46.89%	20.41%	-35.19%	-56.29%	-2.12%	-13.18%	14.14%	-166.01%	-2,462.50%
NOPAT Growth	37.30%	-94.09%	13.45%	-29.35%	-509.18%	40.90%	16.51%	20.41%	63.01%	82.77%
Net Income Growth	84.46%	-63.84%	47.28%	-29.38%	-373.58%	3.05%	-26.23%	5.64%	-132.92%	-1,125.00%
EPS Growth	85.71%	-68.89%	51.00%	-27.71%	-400.00%	2.17%	-24.81%	6.41%	-131.82%	-1,250.00%
Operating Cash Flow Growth	21.27%	-8.57%	-33.99%	-68.65%	30.29%	96.08%	-26.78%	-21.28%	69.46%	-1,421.02%
Free Cash Flow Firm Growth	188.15%	114.20%	181.40%	162.53%	-19.96%	-170.80%	-11,949.34%	-361.59%	-1,077.94%	14.32%
Invested Capital Growth	-5.95%	-2.85%	-3.45%	-4.07%	6.32%	13.20%	14.84%	13.05%	5.93%	4.18%
Revenue Q/Q Growth	71.02%	-61.94%	36.06%	21.18%	43.13%	-57.15%	23.77%	27.69%	37.74%	-55.58%
EBITDA Q/Q Growth	1,571.11%	-97.78%	78.36%	234.08%	1,677.50%	-105.97%	38.57%	223.66%	320.50%	-113.14%
EBIT Q/Q Growth	126.10%	-140.38%	168.45%	300.38%	32.38%	-133.10%	44.49%	583.23%	55.82%	-128.15%
NOPAT Q/Q Growth	77.24%	-126.89%	146.75%	376.75%	29.54%	-115.72%	53.67%	3,678.93%	93.16%	-130.99%
Net Income Q/Q Growth	92.51%	-149.34%	149.65%	268.53%	21.07%	-144.35%	19.70%	1,230.19%	83.84%	-133.74%
EPS Q/Q Growth	93.42%	-150.33%	151.67%	271.43%	22.22%	-145.00%	20.48%	1,285.71%	84.78%	-134.59%
Operating Cash Flow Q/Q Growth	8,428.07%	-121.27%	109.60%	-179.91%	7,556.19%	-112.93%	124.52%	-164.04%	324.47%	-341.39%
Free Cash Flow Firm Q/Q Growth	180.42%	-77.17%	31.91%	200.72%	54.84%	-30.88%	-1.33%	-100.29%	-1.95%	-5,826.75%
Invested Capital Q/Q Growth	-16.54%	0.00%	0.74%	11.87%	-13.80%	-0.61%	0.09%	23.98%	-8.21%	0.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.25%	32.72%	52.26%	43.23%	36.17%	36.45%	48.11%	43.26%	34.38%	32.34%
EBITDA Margin	18.90%	1.93%	33.18%	25.31%	34.04%	-3.09%	22.17%	19.80%	11.53%	-7.20%
Operating Margin	3.24%	-19.78%	24.82%	13.85%	-4.51%	-9.15%	21.51%	17.98%	-0.47%	-14.44%
EBIT Margin	3.72%	-24.38%	22.97%	11.64%	-7.04%	-14.90%	19.29%	16.52%	-4.37%	-13.61%
Profit (Net Income) Margin	-0.98%	-22.40%	17.28%	9.42%	-6.77%	-12.28%	11.86%	12.26%	-1.39%	-11.81%
Tax Burden Percent	-44.32%	82.31%	78.92%	87.76%	77.71%	71.62%	66.14%	77.19%	-2.16%	82.83%
Interest Burden Percent	59.46%	111.64%	95.30%	92.16%	123.75%	115.03%	92.97%	96.16%	-1,467.66%	104.76%
Effective Tax Rate	156.82%	0.00%	21.08%	21.99%	0.00%	0.00%	18.82%	21.78%	-6.61%	0.00%
Return on Invested Capital (ROIC)	-1.29%	-8.09%	11.59%	6.39%	-2.25%	-4.08%	11.25%	9.11%	-0.38%	-6.91%
ROIC Less NNEP Spread (ROIC-NNEP)	-8.37%	-14.18%	6.22%	4.34%	8.58%	-11.93%	-25.11%	3.20%	0.82%	288.71%
Return on Net Nonoperating Assets (RNNOA)	0.16%	-1.83%	0.63%	0.52%	-0.42%	-0.91%	-0.89%	0.18%	-0.09%	-0.18%
Return on Equity (ROE)	-1.12%	-9.92%	12.22%	6.91%	-2.67%	-5.00%	10.36%	9.30%	-0.47%	-7.10%
Cash Return on Invested Capital (CROIC)	11.19%	7.08%	8.62%	8.89%	0.20%	-5.47%	-7.57%	-6.94%	0.10%	0.10%
Operating Return on Assets (OROA)	1.50%	-9.54%	9.07%	4.40%	-2.83%	-6.17%	7.95%	6.65%	-1.79%	-5.70%
Return on Assets (ROA)	-0.40%	-8.77%	6.82%	3.56%	-2.72%	-5.08%	4.89%	4.94%	-0.57%	-4.94%
Return on Common Equity (ROCE)	-1.11%	-9.83%	12.10%	6.84%	-2.64%	-4.95%	10.27%	9.21%	-0.47%	-7.03%
Return on Equity Simple (ROE_SIMPLE)	0.00%	2.86%	3.61%	2.31%	0.00%	3.75%	3.57%	4.65%	0.00%	5.52%
Net Operating Profit after Tax (NOPAT)	-73	-322	1,197	485	-117	-166	1,055	687	-19	-281
NOPAT Margin	-1.84%	-13.84%	19.59%	10.80%	-3.15%	-6.41%	17.46%	14.06%	-0.50%	-10.11%
Net Nonoperating Expense Percent (NNEP)	7.09%	6.10%	5.37%	2.05%	-10.82%	7.85%	36.36%	5.91%	-1.20%	-295.63%
Return On Investment Capital (ROIC_SIMPLE)	-0.27%	-	-	-	-0.42%	-	-	-	-0.07%	-
Cost of Revenue to Revenue	62.75%	67.28%	47.74%	56.77%	63.83%	63.55%	51.89%	56.74%	65.62%	67.66%
SG&A Expenses to Revenue	18.48%	28.85%	17.24%	16.38%	19.83%	25.87%	17.29%	14.86%	19.97%	23.66%
R&D to Revenue	9.18%	14.96%	5.84%	7.39%	9.63%	12.93%	5.44%	6.47%	8.89%	11.24%
Operating Expenses to Revenue	34.01%	52.49%	27.44%	29.39%	40.68%	45.60%	26.60%	25.29%	34.85%	46.78%
Earnings before Interest and Taxes (EBIT)	148	-567	1,404	523	-261	-386	1,166	807	-167	-378
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	752	45	2,028	1,137	1,262	-80	1,340	967	441	-200
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.65	1.65	1.49	1.64	1.33	1.42	1.53	1.66	1.62	1.63
Price to Tangible Book Value (P/TBV)	8.69	8.10	6.90	8.52	6.95	7.19	7.06	8.57	6.84	7.23
Price to Revenue (P/Rev)	2.32	2.45	2.22	2.41	1.94	2.07	2.29	2.39	2.35	2.36
Price to Earnings (P/E)	43.16	58.56	41.87	72.70	45.42	38.44	43.58	36.05	35.77	29.69
Dividend Yield	1.16%	1.11%	1.19%	1.09%	1.31%	1.50%	1.33%	1.24%	1.27%	1.01%
Earnings Yield	2.32%	1.71%	2.39%	1.38%	2.20%	2.60%	2.29%	2.77%	2.80%	3.37%
Enterprise Value to Invested Capital (EV/IC)	1.66	1.58	1.44	1.57	1.34	1.38	1.48	1.58	1.67	1.61
Enterprise Value to Revenue (EV/Rev)	2.29	2.66	2.40	2.60	1.93	2.30	2.46	2.59	2.24	2.40
Enterprise Value to EBITDA (EV/EBITDA)	9.79	13.58	12.91	25.11	8.87	23.41	20.46	20.07	9.91	10.07
Enterprise Value to EBIT (EV/EBIT)	25.72	40.29	31.63	41.98	25.08	28.09	30.17	28.61	26.02	21.35
Enterprise Value to NOPAT (EV/NOPAT)	31.70	37.10	27.74	32.43	21.78	21.19	25.38	31.62	29.34	39.11
Enterprise Value to Operating Cash Flow (EV/OCF)	8.95	0.00	0.00	0.00	6.37	15.55	0.00	157.78	22.89	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	14.34	21.94	16.45	17.28	703.19	0.00	0.00	0.00	1,738.05	1,598.80
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.11	0.23	0.19	0.19	0.10	0.24	0.20	0.19	0.05	0.11
Long-Term Debt to Equity	0.08	0.08	0.10	0.10	0.09	0.09	0.09	0.05	0.05	0.05
Financial Leverage	-0.02	0.13	0.10	0.12	-0.05	0.08	0.04	0.06	-0.11	0.00
Leverage Ratio	1.70	1.69	1.65	1.75	1.68	1.66	1.62	1.70	1.66	1.63
Compound Leverage Factor	1.01	1.88	1.57	1.62	2.08	1.91	1.51	1.64	-24.37	1.71
Debt to Total Capital	10.11%	18.62%	15.67%	15.65%	8.96%	19.10%	16.72%	16.29%	4.87%	10.21%
Short-Term Debt to Total Capital	2.81%	12.19%	7.47%	7.25%	0.71%	11.83%	9.51%	12.27%	0.09%	5.64%
Long-Term Debt to Total Capital	7.31%	6.43%	8.20%	8.41%	8.25%	7.27%	7.21%	4.02%	4.78%	4.57%
Preferred Equity to Total Capital	0.00%	0.78%	0.00%	0.00%	0.00%	0.76%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.90%	0.79%	0.80%	0.81%	0.87%	0.77%	0.76%	0.78%	0.89%	0.86%
Common Equity to Total Capital	88.99%	80.59%	83.53%	83.54%	90.16%	80.13%	82.52%	82.93%	94.24%	88.93%
Debt to EBITDA	0.68	1.75	1.51	2.66	0.66	3.53	2.52	2.20	0.33	0.70
Net Debt to EBITDA	-0.15	0.95	0.85	1.64	-0.10	2.08	1.24	1.40	-0.53	0.11
Long-Term Debt to EBITDA	0.49	0.61	0.79	1.43	0.61	1.34	1.09	0.54	0.32	0.31
Debt to NOPAT	2.21	4.79	3.24	3.44	1.63	3.20	3.13	3.46	0.98	2.72
Net Debt to NOPAT	-0.49	2.59	1.82	2.12	-0.24	1.88	1.54	2.21	-1.58	0.42
Long-Term Debt to NOPAT	1.60	1.65	1.69	1.85	1.50	1.22	1.35	0.85	0.96	1.22
Altman Z-Score	1.97	1.95	2.14	1.91	1.67	1.76	2.06	1.89	2.02	2.15
Noncontrolling Interest Sharing Ratio	0.98%	0.96%	0.93%	0.95%	0.95%	0.95%	0.92%	0.93%	0.93%	0.96%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.45	1.50	1.72	1.51	1.56	1.58	1.66	1.39	1.56	1.69
Quick Ratio	0.85	0.88	1.07	0.84	0.79	0.86	1.02	0.79	0.84	0.96
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,408	502	2,199	1,667	-1,597	-3,536	-2,702	-2,666	-1,331	-1,306
Operating Cash Flow to CapEx	2,622.65%	-37.01%	235.09%	-1,886.49%	1,006.30%	-64.81%	820.20%	-2,192.72%	2,072.07%	-444.68%
Free Cash Flow to Firm to Interest Expense	23.46	7.61	33.32	40.66	-25.76	-60.96	-32.95	-86.01	-36.98	-72.54
Operating Cash Flow to Interest Expense	158.23	-1.73	8.12	-136.20	126.27	-1.81	9.90	-106.81	166.92	-148.72
Operating Cash Flow Less CapEx to Interest Expense	152.20	-6.39	4.67	-143.41	113.73	-4.60	8.70	-111.68	158.86	-182.17
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.40	0.39	0.39	0.38	0.40	0.41	0.41	0.40	0.41	0.42
Accounts Receivable Turnover	3.03	2.51	2.17	2.03	3.08	2.70	2.35	2.22	3.32	2.83
Inventory Turnover	1.55	1.57	1.80	1.52	1.45	1.72	2.10	1.81	1.74	2.07
Fixed Asset Turnover	4.03	3.90	4.00	3.97	4.03	4.08	4.07	4.12	4.07	4.03
Accounts Payable Turnover	2.29	2.53	2.84	2.56	2.16	2.57	2.96	2.74	2.31	2.66
Days Sales Outstanding (DSO)	120.50	145.15	168.13	179.79	118.54	135.25	155.13	164.13	109.91	128.97
Days Inventory Outstanding (DIO)	236.16	232.89	202.54	240.25	252.23	212.80	173.90	201.44	209.69	176.64
Days Payable Outstanding (DPO)	159.33	144.29	128.58	142.31	168.79	141.77	123.11	133.04	157.76	137.48
Cash Conversion Cycle (CCC)	197.34	233.75	242.09	277.73	201.97	206.29	205.93	232.54	161.85	168.14
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	23,430	28,074	28,073	27,867	24,911	28,898	29,075	29,049	23,431	25,528
Invested Capital Turnover	0.70	0.58	0.59	0.59	0.71	0.64	0.64	0.65	0.77	0.68
Increase / (Decrease) in Invested Capital	-1,481	-824	-1,002	-1,182	1,480	3,370	3,757	3,353	1,312	1,025
Enterprise Value (EV)	38,789	44,273	40,489	43,742	33,258	39,893	43,083	45,914	39,159	41,089
Market Capitalization	39,148	40,697	37,595	40,642	33,384	35,867	40,228	42,464	41,030	40,405
Book Value per Share	$34.61	$35.73	$36.13	$35.53	$35.53	$35.54	$36.88	$35.91	$35.41	$34.57
Tangible Book Value per Share	$6.55	$7.26	$7.82	$6.84	$6.82	$7.03	$8.01	$6.95	$8.40	$7.78
Total Capital	26,733	30,695	30,145	29,648	27,768	31,481	31,774	30,867	26,848	27,937
Total Debt	2,703	5,716	4,724	4,640	2,489	6,014	5,313	5,028	1,307	2,853
Total Long-Term Debt	1,953	1,975	2,471	2,492	2,291	2,290	2,290	1,241	1,283	1,277
Net Debt	-600	3,095	2,652	2,859	-368	3,546	2,614	3,210	-2,110	444
Capital Expenditures (CapEx)	362	308	228	296	778	162	99	151	290	602
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,292	6,473	6,700	6,321	3,307	7,347	7,268	7,154	2,760	5,385
Debt-free Net Working Capital (DFNWC)	5,461	8,966	8,659	7,979	6,049	9,709	9,884	8,885	6,075	7,703
Net Working Capital (NWC)	4,711	5,225	6,406	5,831	5,851	5,985	6,861	5,098	6,051	6,127
Net Nonoperating Expense (NNE)	-34	199	141	62	134	152	338	88	34	47
Net Nonoperating Obligations (NNO)	-600	3,095	2,652	2,859	-368	3,431	2,614	3,210	-2,110	444
Total Depreciation and Amortization (D&A)	604	612	624	614	1,523	306	174	160	608	178
Debt-free, Cash-free Net Working Capital to Revenue	13.56%	38.91%	39.64%	37.55%	19.20%	42.36%	41.46%	40.33%	15.81%	31.47%
Debt-free Net Working Capital to Revenue	32.30%	53.89%	51.23%	47.40%	35.12%	55.98%	56.38%	50.09%	34.80%	45.02%
Net Working Capital to Revenue	27.86%	31.41%	37.90%	34.64%	33.97%	34.51%	39.14%	28.74%	34.67%	35.81%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.04)	($0.76)	$1.51	$0.60	($0.35)	($0.45)	$1.00	$0.84	($0.07)	($0.46)
Adjusted Weighted Average Basic Shares Outstanding	685.56M	687.29M	692.25M	696.98M	701.78M	704.73M	709.76M	710.87M	712.82M	714.49M
Adjusted Diluted Earnings per Share	($0.05)	($0.76)	$1.51	$0.60	($0.35)	($0.45)	$1.00	$0.83	($0.07)	($0.46)
Adjusted Weighted Average Diluted Shares Outstanding	685.56M	687.29M	692.25M	696.98M	701.78M	704.73M	709.76M	710.87M	712.82M	714.49M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	685.56M	687.29M	692.25M	696.98M	701.78M	704.73M	709.76M	710.87M	712.82M	714.49M
Normalized Net Operating Profit after Tax (NOPAT)	153	-300	1,270	544	52	-165	1,104	713	32	-174
Normalized NOPAT Margin	3.84%	-12.88%	20.78%	12.10%	1.40%	-6.35%	18.26%	14.59%	0.82%	-6.28%
Pre Tax Income Margin	2.21%	-27.21%	21.89%	10.73%	-8.71%	-17.14%	17.93%	15.89%	64.08%	-14.26%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.47	-8.59	21.27	12.76	-4.21	-6.66	14.22	26.03	-4.64	-21.00
NOPAT to Interest Expense	-1.22	-4.88	18.14	11.83	-1.89	-2.86	12.87	22.15	-0.53	-15.59
EBIT Less CapEx to Interest Expense	-3.57	-13.26	17.82	5.54	-16.76	-9.45	13.01	21.16	-12.69	-54.44
NOPAT Less CapEx to Interest Expense	-7.25	-9.55	14.69	4.61	-14.43	-5.65	11.66	17.28	-8.59	-49.04
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	254.30%	63.93%	49.34%	77.76%	58.77%	45.93%	45.78%	35.55%	36.10%	30.10%
Augmented Payout Ratio	364.09%	195.19%	151.32%	210.16%	159.97%	128.99%	124.06%	121.01%	122.45%	102.99%

Frequently Asked Questions About Corteva's Financials

When does Corteva's financial year end?

According to the most recent income statement we have on file, Corteva's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Corteva's net income changed over the last 6 years?

Corteva's net income appears to be on a downward trend, with a most recent value of $919 million in 2024, falling from -$5.03 billion in 2018. The previous period was $747 million in 2023. See where experts think Corteva is headed by visiting Corteva's forecast page.

What is Corteva's operating income?

Corteva's total operating income in 2024 was $1.81 billion, based on the following breakdown:

Total Gross Profit: $7.38 billion
Total Operating Expenses: $5.57 billion

How has Corteva revenue changed over the last 6 years?

Over the last 6 years, Corteva's total revenue changed from $14.29 billion in 2018 to $16.91 billion in 2024, a change of 18.3%.

How much debt does Corteva have?

Corteva's total liabilities were at $16.80 billion at the end of 2024, a 5.2% decrease from 2023, and a 75.0% decrease since 2018.

How much cash does Corteva have?

In the past 6 years, Corteva's cash and equivalents has ranged from $1.76 billion in 2019 to $4.54 billion in 2018, and is currently $3.11 billion as of their latest financial filing in 2024.

How has Corteva's book value per share changed over the last 6 years?

Over the last 6 years, Corteva's book value per share changed from 0.00 in 2018 to 34.61 in 2024, a change of 3,461.3%.

Related Companies

This page (NYSE:CTVA) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Corteva (CTVA) Financials

Frequently Asked Questions About Corteva's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Corteva (CTVA) Financials

Annual Income Statements for Corteva

Quarterly Income Statements for Corteva

Annual Cash Flow Statements for Corteva

Quarterly Cash Flow Statements for Corteva

Annual Balance Sheets for Corteva

Quarterly Balance Sheets for Corteva

Annual Metrics And Ratios for Corteva

Quarterly Metrics And Ratios for Corteva

Frequently Asked Questions About Corteva's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools